Evidence map›Paper›PMID 35940947›Full record

ArticleTransplantation proceedings2022

Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool.

Sasha Storaasli, Shunichi Nakagawa, Jonathan P Singer, David A Fedoronko, Yuan Zhang, Demetra Tsapepas, Maylin E Rincon, Jenna Scheffert, Luke Benvenuto, Selim M Arcasoy

Open access · greenAbstract read
In one paragraph

Article in Transplantation proceedings, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sasha StoraasliDepartment of Social Work, New York-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY. Electronic address: sas9167@nyp.org.
Shunichi NakagawaAdult Palliative Care Service, Department of Medicine, Columbia University Medical Center, New York, NY.
Jonathan P SingerDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California San Francisco, San Francisco, CA.
David A FedoronkoDepartment of Psychiatry, Columbia University Medical Center, New York, NY.
Yuan ZhangDepartment of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, NY.
Demetra TsapepasDepartment of Quality and Research-Transplantation, New York-Presbyterian Hospital, New York, NY.
Maylin E RinconDivision of Pulmonary, Allergy and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY.
Jenna ScheffertDepartment of Transplant Pharmacy, New York-Presbyterian Hospital, New York, NY.
Luke BenvenutoDivision of Pulmonary, Allergy and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY.
Selim M ArcasoyDivision of Pulmonary, Allergy and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY.
Columbia University Irving Medical Center · USNewYork–Presbyterian Hospital · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are 2 main aims of lung transplantation for people with end-stage lung disease: (1) to extend life and (2) to improve its quality. Much consideration is given to how to support the longevity and functioning of the allograft, though less robust studies have been done on the quality of the recipients' lives. With an interest in providing compassionate and holistic patient-centered care, it is vital that the treatment providers accurately understand their patients' lived experience. This study aimed to describe the health-related quality of life experiences of lung transplant recipients. An interest was held for where patients may struggle, thus informing where support might be needed to achieve the best possible outcomes.

methodsThis single-center study used a validated Lung Transplant Quality of Life questionnaire, which was sent in autumn of 2020 to all of the lung transplant recipients (n = 581) under the care of Columbia University Irving Medical Center (New York, NY).

results"Anxiety/Depression" had the highest concentration of struggle responses, followed closely by "Pulmonary Symptoms" and "Neuromuscular Symptoms." "Neuromuscular Problems" and "Sexual Problems" had the highest percentage of struggle responses. As the struggles increased, the overall quality of life rating dropped proportionately. There was no correlation between the overall quality of life and graft dysfunction, age, or time out from transplant date. All of the domains held an average rating of "Satisfactory," except "Treatment Burden," which was rated as "Favorable." Those ratings dropped for the cohort of patients who died during the study period.

conclusionsWith the goal of providing comprehensive care at the forefront of transplant priorities, we found the newly developed questionnaire invaluable in targeting areas for quality improvements, mostly notably respecting recipient mental health.

Indexed as

COVID-19Lung TransplantationHumansLungPandemicsQuality of LifeTransplant Recipients

Identifiers

PMID35940947
PMCPMC9271457
OpenAlexW4285014483

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.